Phil
Medication Access, Simplified.
San Francisco, United States · Founded 2015 · $91.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- phil.us
- Total Funding
- $91.0M
- Last Round
- $56.0M Series DJun 2021
- Rounds
- 4
About
Software therapy deployment platform simplifying prescription management, delivery, and patient access for pharmaceutical manufacturers and patients. PHIL's digital hub solves medication access and GTN challenges for retail and specialty-lite brands, maximizing patient enrollment, prior authorizations, covered dispenses, and adherence through integrated pharmacy networks and end-to-end visibility.
Summary
Phil is a Drug Discovery company based in San Francisco, United States, founded in 2015. It has raised $91.0M in total across 4 rounds, most recently a $56.0M Series D round in Jun 2021. Investors include Crosslink Capital, K2 HealthVentures and Warburg Pincus.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...